Suplasyn/Suplasyn 1-Shot Special Precautions

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Presentation/Packing

Full Prescribing Info

Special Precautions

Respect usual precautions and contraindications for any intra-articular injection. Do not inject intra-vascularly. SUPLASYN should not be used in patients presenting an inflammation/irritation of the joint, since adverse events more commonly occur in patients with already existing joint inflammation/irritation. As no clinical evidence is available on the use of Hyaluronic Acid in children, pregnant and lactating women, treatment with SUPLASYN is not recommended in these patients. The patient should rest 24-48 hours after the injection and avoid any strenuous activity over the full course of the treatment.

Suplasyn/Suplasyn 1-Shot Special Precautions

sodium hyaluronate

Manufacturer:

Viatris Pharma

Distributor:

Viatris Pharma